The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

January 5, 2026 

HRSA Pauses 340B Rebate Model Pilot Program  

Pharmacies should know that the 340B Rebate Model Pilot Program (the Pilot), previously set to be in effect January 1, 2026 and that NCPA previously reported on and covered in a webinar, is currently paused. For now, pharmacies should proceed with their 340B business as usual.

On December 31, 2025, the Health Resources and Services Administration’s Office of Pharmacy Affairs (OPA) stated that it is pausing the implementation of the Pilot for all covered entity types at this time. Manufacturers who were approved for participation in the Pilot to effectuate 340B pricing through a rebate mechanism will now be required to continue to offer all of their covered outpatient drugs to 340B covered entities at the 340B ceiling price as an up-front discount. OPA will update stakeholders on developments regarding the Pilot as they arise.

This follows a US District Judge in the District of Maine granting a temporary restraining order on December 18, 2025 blocking the Pilot, followed by a December 29, 2025 preliminary injunction of the court preventing the government from implementing the Pilot pending further order. The judge’s ruling is a temporary pause of the Pilot while the case proceeds. 

In the case, Plaintiffs American Hospital Association, the Maine Hospital Association and four safety-net hospitals had brought a suit on December 1, 2025 arguing that the Pilot violates the Administrative Procedure Act. Plaintiffs argued that the Pilot would impose significant administrative and financial burdens on safety-net providers, and that the financial burdens specifically would amount to “hundreds of millions” in annual costs.